Featured Research

from universities, journals, and other organizations

Early Detection Of Cerebral Malaria Possible, Animal Study Indicates

Date:
February 19, 2008
Source:
Journal of Clinical Investigation
Summary:
Cerebral malaria kills over 3 million individuals a year. One of the main causes of disease is the adherence of blood cells known as platelets to small blood vessels in the brain. Currently, platelet accumulation can only be detected after the clinical signs of the disease are visible. However, researchers have now developed a new agent that enables platelet accumulation to be detected in the mouse brain before the clinical signs of disease are visible.

Cerebral malaria (CM), which kills over 3 million individuals a year, is caused by infection with Plasmodium falciparum. One of the main causes of disease symptoms is the adherence of blood cells known as platelets to the small blood vessels (microvasculature) in the brain.

Currently there is no way to detect such platelet accumulation until after the clinical signs of the disease are visible. However, a new way to detect platelet accumulation in the microvasculature of the mouse brain has now been developed by Daniel Anthony and colleagues at the University of Oxford, United Kingdom.

In the study, a protein (known as a single-chain antibody) that specifically binds a region of the GPIIb/IIIa receptor that is expressed only on activated platelets was attached to microparticles of iron oxide.

Using this contrast reagent, it was possible to detect by magnetic resonance imaging (MRI) activated platelets in the brain of mice 6 days after they were infected with Plasmodium berghei.

At this time point after infection, clinical symptoms of the disease had not appeared and activated platelets in the brain could not be detected by conventional MRI.

These data led the authors to suggest that targeted contrast reagents similar to the one described in their study might prove useful for diagnostic, mechanistic, and therapeutic analyses.

Journal reference: A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI. Journal of Clinical Investigation. February 14, 2008.


Story Source:

The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Cite This Page:

Journal of Clinical Investigation. "Early Detection Of Cerebral Malaria Possible, Animal Study Indicates." ScienceDaily. ScienceDaily, 19 February 2008. <www.sciencedaily.com/releases/2008/02/080215103259.htm>.
Journal of Clinical Investigation. (2008, February 19). Early Detection Of Cerebral Malaria Possible, Animal Study Indicates. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2008/02/080215103259.htm
Journal of Clinical Investigation. "Early Detection Of Cerebral Malaria Possible, Animal Study Indicates." ScienceDaily. www.sciencedaily.com/releases/2008/02/080215103259.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins